drugset / Trial / NCT07837115

A Study to Assess the Relative Bioavailability of Irafamdastat (BMS-986368) and to Assess the Food Effect on the Pharmacokinetics of Irafamdastat in Healthy Adult Participants

NCT07837115 ↗

Phase 1 Not yet recruiting 24 enrolled Celgene Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the relative bioavailability of irafamdastat and to assess food-effect on the pharmacokinetics (PK) of irafamdastat ODT in healthy adult participants.

Timeline

Start
2026-10-06
Primary completion
2026-12-19
Completion
2026-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986368 Unknown — Oral

Indications

No indication recorded.